Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entospletinib with Vincristine and Dexamethasone in R/R ALL
NCT02404220Phase 2Terminated
- Sponsor
- Gilead Sciences
- Start
- May 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of entospletinib in acute lymphoblastic leukemia (ALL), sponsored by Gilead Sciences. Started May 2015; status: terminated.
02
Drugs
entospletinib
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02404220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02404220.